Evidence map›Paper›PMID 27565834›Full record

ReviewMutagenesis2017

Emerging metrology for high-throughput nanomaterial genotoxicology.

Bryant C Nelson, Christa W Wright, Yuko Ibuki, Maria Moreno-Villanueva, Hanna L Karlsson, Giel Hendriks, Christopher M Sims, Neenu Singh, Shareen H Doak

Open access · bronzeAbstract readReview
In one paragraph

Review in Mutagenesis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Genotoxicity of TiONanomaterials (Basel, Switzerland) · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Advantages of evaluating γH2AX induction in non-clinical drug development.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 5 countries.

Bryant C NelsonNational Institute of Standards and Technology, Material Measurement Laboratory - Biosystems and Biomaterials Division, 100 Bureau Drive, Gaithersburg, MD 20899, USA, bryant.nelson@nist.gov.
Christa W WrightDepartment of Environmental Health, Center for Nanotechnology and Nanotoxicology, Harvard T.H. Chan School of Public Health, 665 Huntington Avenue Building 1/Room 1309, Boston, MA 02115, USA.
Yuko IbukiGraduate Division of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan.
Maria Moreno-VillanuevaDepartment of Biology, University of Konstanz, Molecular Toxicology Group, D-78457 Konstanz, Germany.
Hanna L KarlssonUnit of Biochemical Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden.
Giel HendriksToxys, Robert Boyleweg 4, 2333 CG Leiden, The Netherlands.
Christopher M SimsNational Institute of Standards and Technology, Material Measurement Laboratory - Biosystems and Biomaterials Division, 100 Bureau Drive, Gaithersburg, MD 20899, USA.
Neenu SinghFaculty of Health and Life Sciences, School of Allied Health Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK and.
Shareen H DoakSwansea University Medical School, Institute of Life Science, Centre for NanoHealth, Swansea University Medical School, Wales SA2 8PP, UK.
De Montfort University · GBHarvard University · USKarolinska Institutet · SEMaterial Measurement Laboratory · USNational Institute of Standards and Technology · USSwansea University · GBUniversity of Konstanz · DEUniversity of Shizuoka · JP

Funding

Intramural NIST DOC 9999-NIST
6 · The paper itself

Abstract

The rapid development of the engineered nanomaterial (ENM) manufacturing industry has accelerated the incorporation of ENMs into a wide variety of consumer products across the globe. Unintentionally or not, some of these ENMs may be introduced into the environment or come into contact with humans or other organisms resulting in unexpected biological effects. It is thus prudent to have rapid and robust analytical metrology in place that can be used to critically assess and/or predict the cytotoxicity, as well as the potential genotoxicity of these ENMs. Many of the traditional genotoxicity test methods [e.g. unscheduled DNA synthesis assay, bacterial reverse mutation (Ames) test, etc.,] for determining the DNA damaging potential of chemical and biological compounds are not suitable for the evaluation of ENMs, due to a variety of methodological issues ranging from potential assay interferences to problems centered on low sample throughput. Recently, a number of sensitive, high-throughput genotoxicity assays/platforms (CometChip assay, flow cytometry/micronucleus assay, flow cytometry/γ-H2AX assay, automated 'Fluorimetric Detection of Alkaline DNA Unwinding' (FADU) assay, ToxTracker reporter assay) have been developed, based on substantial modifications and enhancements of traditional genotoxicity assays. These new assays have been used for the rapid measurement of DNA damage (strand breaks), chromosomal damage (micronuclei) and for detecting upregulated DNA damage signalling pathways resulting from ENM exposures. In this critical review, we describe and discuss the fundamental measurement principles and measurement endpoints of these new assays, as well as the modes of operation, analytical metrics and potential interferences, as applicable to ENM exposures. An unbiased discussion of the major technical advantages and limitations of each assay for evaluating and predicting the genotoxic potential of ENMs is also provided.

Indexed as

DNA DamageAnimalsBacteriaDNAHigh-Throughput Screening AssaysHumansMutagenicity TestsNanostructuresDNA

Identifiers

PMID27565834
PMCPMC5500194
OpenAlexW2509242802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.